Astria Therapeutics
Cambridge
About Astria Therapeutics
Astria Therapeutics is a biopharmaceutical company devoted to developing life-changing therapies for allergic and immunologic diseases. The company is advancing a pipeline of therapeutic candidates, including Navenibart for Hereditary Angioedema and STAR-0310 for Atopic Dermatitis. Astria Therapeutics conducts clinical trials and research, guided by the patient community, to create new treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $656.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 2024)
- Ticker: nasdaq:CATB
- Website: astriatx.com
- Phone: (617) 349-1971
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/astria-therapeutics-115518 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.